This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Taiwan University. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations of Feng-Chiao Tsai in Serotype Identification
Introduction
Feng-Chiao Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of molecular biology, particularly in the identification of serotypes using advanced techniques.
Latest Patents
Feng-Chiao Tsai holds 1 patent related to a method of identifying a serotype. This invention utilizes specific polymerase chain reaction (PCR) primer sets designed according to a fragment of a capsular polysaccharide synthesis (cps) region. The method is particularly aimed at identifying a K57 or a NTUH-N1 serotype, which is a novel serotype differing from the previously reported 77 serotypes. This PCR-based cps genotyping method addresses the issues of insufficient specificity and sensitivity associated with conventional immune methods. It can be applied in clinical diagnosis, offering advantages such as rapidity and low cost. Additionally, this method reduces the rate of unidentifiable strains.
Career Highlights
Feng-Chiao Tsai is affiliated with National Taiwan University, where he continues to engage in research and development in his field. His work has been instrumental in advancing the methodologies used in serotype identification.
Collaborations
Feng-Chiao Tsai has collaborated with notable colleagues, including Jin-Town Wang and Yi-Jiun Pan, contributing to the advancement of their shared research interests.
Conclusion
Feng-Chiao Tsai's innovative approach to serotype identification through PCR technology represents a significant advancement in clinical diagnostics. His contributions continue to impact the field positively.